Le Lézard
Classified in: Health
Subjects: RCL, CFG

Food Recall Warning (Allergen) - Walkers brand Mint Thins recalled due to undeclared milk


Product photos are available at: https://inspection.canada.ca/eng/1635562524460/1635562530177

OTTAWA, ON, Oct. 29, 2021 /CNW/ - Dollarama S.E.C /L.P is recalling Walkers brand Mint Thins from the marketplace because they may contain milk which is not declared on the label. People with an allergy to milk should not consume the recalled product described below.

The following product has been sold nationally.

Recalled product

Brand

Product

Size

UPC

Codes

Walkers

Mint Thins

150 g

0 11555 02481 6

Lot 1175
Best Before:

2022 DE 24

 

Lot 1174
Best Before:

2022 DE 23

 

Lot 1179
Best Before:

2022 DE 28

What you should do

Check to see if you have the recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to milk, do not consume the recalled product as they may cause a serious or life-threatening reaction.

Background

This recall was triggered by the company. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Reactions

There has been one reported reaction associated with the consumption of this product.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...

16 mai 2024
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

16 mai 2024
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...



News published on and distributed by: